Insider Transactions in Q3 2024 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
30,000
-50.76%
|
$870,000
$29.03 P/Share
|
|
Sep 13
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,020
-0.88%
|
$30,600
$30.0 P/Share
|
|
Sep 03
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,080
-1.29%
|
$77,000
$25.18 P/Share
|
|
Aug 21
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,547
-1.41%
|
$61,128
$24.78 P/Share
|
|
Aug 21
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,005
-7.45%
|
$480,120
$24.68 P/Share
|
|
Aug 20
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
5,806
-1.57%
|
$133,538
$23.67 P/Share
|
|
Aug 20
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,727
-5.02%
|
$39,721
$23.79 P/Share
|
|
Aug 20
2024
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
2,260
-0.95%
|
$51,980
$23.79 P/Share
|
|
Aug 20
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,453
-1.74%
|
$56,419
$23.79 P/Share
|
|
Aug 13
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,272
-1.2%
|
$49,984
$22.89 P/Share
|
|
Aug 13
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,337
-1.63%
|
$51,414
$22.89 P/Share
|
|
Jul 01
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,080
-1.26%
|
$67,760
$22.49 P/Share
|
|
Jul 01
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
30,000
-23.36%
|
$660,000
$22.46 P/Share
|